Article Details
Retrieved on: 2021-05-11 14:18:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Earnings And Revenue. Sell-side analysts are expecting Strongbridge Biopharma's loss per share to be near $0.1 on sales of $8.31 million.
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here